Sera Prognostics (SERA) Cash from Financing Activities (2020 - 2026)
Sera Prognostics' (SERA) quarterly Cash from Financing Activities came in at $20000.0 in Q1 2026, down 99.96% YoY from $53.5 million in Q1 2025, and down 78.49% on a QoQ basis from $93000.0 in Q4 2025.
Sera Prognostics (SERA) Cash from Financing Activities (2020 - 2026) Analysis & Trends
Sera Prognostics (SERA) has 7 years of Cash from Financing Activities data on file, last reported at $20000.0 in Q1 2026.
- Quarterly Cash from Financing Activities fell 99.96% year-over-year to $20000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $504000.0 (down 99.09% YoY) and the FY2025 annual result came in at $54.0 million, up 1970.76% from the prior year.
- Cash from Financing Activities declined to $20000.0 in Q1 2026, from $93000.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $53.5 million in Q1 2025 to a low of -$116000.0 in Q4 2022.
- A 5-year average of $3.4 million and a median of $117000.0 in 2024 frame the typical range for Cash from Financing Activities.
- Annual changes were most pronounced in 2022 — Cash from Financing Activities tumbled 413.51% — and 2025, when it surged 4979.89%.
- Tracing SERA's Cash from Financing Activities over 5 years: stood at -$116000.0 in 2022, then surged by 631.03% to $616000.0 in 2023, then plunged by 62.01% to $234000.0 in 2024, then plunged by 60.26% to $93000.0 in 2025, then slumped by 78.49% to $20000.0 in 2026.
- The last three Cash from Financing Activities figures came in at $20000.0 (Q1 2026), $93000.0 (Q4 2025), and $373000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | -3.52 Bn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | -95.00 Mn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | -410.00 Mn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | -300,000.00 |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | -607.30 Mn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | -236.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | -1.34 Bn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | -213.50 Mn |
| 10 | Sera Prognostics | 103.48 Mn | 103.48 Mn | -20,000.00 | 140,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 140,000.00 |
| Jun 30, 2026 | 140,000.00 |
| Mar 31, 2026 | 20,000.00 |
| Mar 31, 2026 | 20,000.00 |
| Dec 31, 2025 | 93,000.00 |
| Dec 31, 2025 | 93,000.00 |
| Sep 30, 2025 | 373,000.00 |
| Sep 30, 2025 | 373,000.00 |
| Jun 30, 2025 | 18,000.00 |
| Jun 30, 2025 | 18,000.00 |
| Mar 31, 2025 | 53.54 Mn |
| Mar 31, 2025 | 53.54 Mn |
| Dec 31, 2024 | 234,000.00 |
| Dec 31, 2024 | 234,000.00 |
| Sep 30, 2024 | 117,000.00 |
| Sep 30, 2024 | 117,000.00 |
| Jun 30, 2024 | 1.20 Mn |
| Jun 30, 2024 | 1.20 Mn |
| Mar 31, 2024 | 1.05 Mn |
| Mar 31, 2024 | 1.05 Mn |